ZNF518B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.216170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.094800E-01
Normal-vs-Stage2
1.546390E-02
Normal-vs-Stage3
2.156600E-01
Normal-vs-Stage4
2.655600E-01
Stage1-vs-Stage2
3.491200E-01
Stage1-vs-Stage3
1.189840E-01
Stage1-vs-Stage4
7.510600E-01
Stage2-vs-Stage3
9.984800E-03
Stage2-vs-Stage4
7.213000E-01
Stage3-vs-Stage4
1.574970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.302250E-02
Normal-vs-AfricanAmerican
3.078400E-01
Normal-vs-Asian
2.340800E-01
Caucasian-vs-AfricanAmerican
2.187000E-01
Caucasian-vs-Asian
2.297800E-01
AfricanAmerican-vs-Asian
3.581700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.035400E-03
Normal-vs-Female
2.991600E-02
Male-vs-Female
1.478220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.330200E-01
Normal-vs-Age(41-60Yrs)
3.952200E-01
Normal-vs-Age(61-80Yrs)
5.798300E-03
Normal-vs-Age(81-100Yrs)
4.194000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.018020E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.551670E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.921600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.476800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.171840E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.889600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.445000E-01
Normal-vs-Daily Drinker
2.185400E-01
Normal-vs-Weekly Drinker
5.988100E-02
Normal-vs-Occasional Drinker
2.995200E-01
Normal-vs-Social Drinker
2.269400E-01
Non Drinker-vs-Daily Drinker
4.568000E-01
Non Drinker-vs-Weekly Drinker
1.340800E-01
Non Drinker-vs-Occasional Drinker
2.830400E-01
Non Drinker-vs-Social Drinker
9.961700E-02
Daily Drinker-vs-Weekly Drinker
4.144100E-02
Daily Drinker-vs-Occasional Drinker
9.112300E-02
Daily Drinker-vs-Social Drinker
4.632500E-02
Weekly Drinker-vs-Occasional Drinker
6.357000E-01
Weekly Drinker-vs-Social Drinker
5.575400E-01
Occasional Drinker-vs-Social Drinker
3.044800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.327600E-01
Normal-vs-Grade 2
8.279200E-01
Normal-vs-Grade 3
7.496000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.085200E-01
Grade 1-vs-Grade 3
8.948600E-01
Grade 1-vs-Grade 4
7.327600E-01
Grade 2-vs-Grade 3
5.593400E-01
Grade 2-vs-Grade 4
8.279200E-01
Grade 3-vs-Grade 4
7.496000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.763600E-01
Normal-vs-NonDiabetic
2.825000E-01
Diabetic-vs-NonDiabetic
8.403000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.686600E-01
Normal-vs-NoPancreatitis
2.889200E-01
Pancreatitis-vs-NoPancreatitis
6.547200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.419730E-02
Normal-vs-N1
1.567580E-02
N0-vs-N1
5.152000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.056600E-03
Normal-vs-TP53-NonMutant
4.641700E-02
TP53-Mutant-vs-TP53-NonMutant
8.644100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
